Functional interaction of Oct transcription factors with the family of repeats in Epstein-Barr virus oriP

Journal of General Virology

Volumn 86, Issue 5, 2005, Pages 1261-1267

  Almqvist, J ^a   Zou, J ^a   Liderson, Y ^a   Borestrom, C ^b   Altiok, E ^c   Zetterberg, H ^b   Rymo, L ^b   Pettersson, S ^a   Ernberg, Ingermar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Acibadem Genetik Tani ve Hucre Tedavileri Merkezi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN ORIP; REGULATOR PROTEIN; THYMIDINE KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

B-LYMPHOCYTES; CELL LINE; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; OCTAMER TRANSCRIPTION FACTOR-1; OCTAMER TRANSCRIPTION FACTOR-2; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; REPETITIVE SEQUENCES, NUCLEIC ACID; REPLICATION ORIGIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

HUMAN HERPESVIRUS 4;

EID: 18144401210     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80620-0     Document Type: Article

References (35)

1. Ambinder, R. F., Shah, W. A., Rawlins, D. R., Hayward, G. S. & Hayward, S. D. (1990). Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J Virol 64, 2369-2379.
2. Ben-Bassat, H., Goldblum, N., Mitrani, S. & 7 other authors (1977). Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer 19, 27-33.
3. Boreström, C., Zetterberg, H., Liff, K. & Rymo, L. (2003). Functional interaction of nuclear factor Y and Sp1 is required for activation of the Epstein-Barr virus C promoter. J Virol 77, 821-829.
4. Chen, F., Zou, J.-Z., di Renzo, L., Winberg, G., Hu, L.-F., Klein, E., Klein, G. & Ernberg, I. (1995). A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol 69, 3752-3758.
5. Das, G. & Herr, W. (1993). Enhanced activation of the human histone H2B promoter by an Oct-1 variant generated by alternative splicing. J Biol Chem 268, 25026-25032.
6. Dawson, S. J., Yoon, S. O., Chikaraishi, D. M., Lillycrop, K. A. & Latchman, D. S. (1994). The Oct-2 transcription factor represses tyrosine hydroxylase expression via a heptamer TAATGARAT-like motif in the gene promoter. Nucleic Acids Res 22, 1023-1028.
7. Ernberg, I., Falk, K., Minarovits, J., Busson, P., Tursz, T., Masucci, M. G. & Klein, G. (1989). The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. J Gen Virol 70, 2989-3002.
8. Gahn, T. A. & Sugden, B. (1995). An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol 69, 2633-2636.
9. Jin, X. W. & Speck, S. H. (1992). Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J Virol 66, 2846-2852.
10. Jones, C. H., Hayward, S. D. & Rawlins, D. R. (1989). Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites. J Virol 63, 101-110.
11. Klein, G., Dombos, L. & Gothoskar, B. (1972). Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int J Cancer 10, 44-57.
12. Kupfer, S. R. & Summers, W. C. (1990). Identification of a glucocorticoid-responsive element in Epstein-Barr virus. J Virol 64, 1984-1990.
13. Längle-Rouault, F., Patzel, V., Benavente, A., Taillez, M., Silvestre, N., Bompard, A., Sczakiel, G., Jacobs, E. & Rittner, K. (1998). Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J Virol 72, 6181-6185.
14. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G. & Masucci, M. G. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375, 685-688.
15. Lillycrop, K. A. & Latchman, D. S. (1992). Alternative splicing of the Oct-2 transcription factor RNA is differentially regulated in neuronal cells and B cells and results in protein isoforms with opposite effects on the activity of octamer/TAATGARAT-containing promoters. J Biol Chem 267, 24960-24965.
16. Lillycrop, K. A., Dent, C. L., Wheatley, S. C., Beech, M. N., Ninkina, N. N., Wood, J. N. & Latchman, D. S. (1991). The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons. Neuron 7, 381-390.
17. Liu, Y.-Z., Lillycrop, K. A. & Latchman, D. S. (1995). Regulated splicing of the Oct-2 transcription factor RNA in neuronal cells. Neurosci Lett 183, 8-12.
18. Müller, M. M., Ruppert, S., Schaffner, W. & Matthias, P. (1988). A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature 336, 544-551.
19. Nilsson, T., Sjöblom, A., Masucci, M. G. & Rymo, L. (1993). Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Virology 193, 774-785.
20. Nilsson, T., Zetterberg, H., Wang, Y. C. & Rymo, L. (2001). Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. J Virol 75, 5796-5811.
21. Nordeen, S. K. (1988). Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6, 454-458.
22. Puglielli, M. T., Woisetschlaeger, M. & Speck, S. H. (1996). oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol 70, 5758-5768.
23. Rawlins, D. R., Milman, G., Hayward, S. D. & Hayward, G. S. (1985). Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42, 859-868.
24. Reisman, D. & Sugden, B. (1986). trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol 6, 3838-3846.
25. Scheidereit, C., Heguy, A. & Roeder, R. G. (1987). Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitro. Cell 51, 783-793.
26. Sturm, R. A., Das, G. & Herr, W. (1988). The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev 2, 1582-1599.
27. Sugden, B. & Warren, N. (1989). A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol 63, 2644-2649.
28. Sung, N. S., Kenney, S., Gutsch, D. & Pagano, J. S. (1991). EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J Virol 65, 2164-2169.
29. Sung, N. S., Wilson, J., Davenport M., Sista, N. D. & Pagano, J. S. (1994). Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol Cell Biol 14, 7144-7152.
30. Tanaka, M., Grossniklaus, U., Herr, W. & Hernandez, N. (1988). Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements. Genes Dev 2, 1764-1778.
31. Tomilin, A., Reményi, A., Lins, K., Bak, H., Leidel, S., Vriend, G., Wilmanns, M. & Schöler, H. R. (2000). Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell 103, 853-864.
32. Wirth, T., Priess, A., Annweiler, A., Zwilling, S. & Oeler, B. (1991). Multiple Oct2 isoforms are generated by alternative splicing. Nucleic Acids Res 19, 43-51.
33. Wysokenski, D. A. & Yates, J. L. (1989). Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J Virol 63, 2657-2666.
34. Yates, J., Warren, N., Reisman, D. & Sugden, B. (1984). A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A 81, 3806-3810.
35. Zetterberg, H., Boreström, C., Nilsson, T. & Rymo, L. (2004). Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter. Int J Oncol 25, 693-696.